** Shares of Maryland-based drugmaker Emergent BioSolutions EBS.N rise 11.8% to $5.21
** EBS authorizes the repurchase of up to $50 million of the company's common stock on or before March 27, 2026
** EBS has 54.3 million outstanding shares, with a market capitalization of $253.2 million according to data compiled by LSEG
** As of last close, EBS has risen 84% in the past 12 months
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。